Sestron Clinical Research 833 Campbell Hill Street Suite 230 — Marietta, Georgia

Sestron Clinical Research 833 Campbell Hill Street Suite 230 is a clinical research site located in Marietta, Georgia, United States 30060.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Sestron Clinical Research 833 Campbell Hill Street Suite 230 has participated in 1 clinical trials.

Therapeutic areas: Hyperlipidemia.

Sponsors: Arisaph Pharmaceuticals Inc.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sestron Clinical Research 833 Campbell Hill Street Suite 230?

Sestron Clinical Research 833 Campbell Hill Street Suite 230 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sestron Clinical Research 833 Campbell Hill Street Suite 230 conducted?

Sestron Clinical Research 833 Campbell Hill Street Suite 230 has 1 clinical trials on record. Their work covers Hyperlipidemia.

Is Sestron Clinical Research 833 Campbell Hill Street Suite 230 accredited by Crixeo Health?

Sestron Clinical Research 833 Campbell Hill Street Suite 230 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sestron Clinical Research 833 Campbell Hill Street Suite 230?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.